Brain training showdown: continuous vs. intermittent feedback in fMRI study
NCT ID NCT07389486
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether continuous or intermittent real-time fMRI neurofeedback is better at helping healthy adults control a brain region called the anterior insula, which is involved in emotions and body awareness. Ninety participants will undergo either real or sham neurofeedback while their brain activity is monitored. The goal is to see which feedback style leads to greater brain changes and improvements in empathy and heartbeat perception.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- real-time fMRI neurofeedback training procedure
- What this could lead to
- If successful, this could point toward more effective brain-training methods for regulating emotions and improving empathy.
- What could go wrong
- This is an early-stage study in healthy volunteers, not a treatment trial. Results may not apply to clinical populations, and the training effects might be small or temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Electronic Science and Technology of China
RECRUITINGChengdu, Sichuan, 611731, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test